Your browser doesn't support javascript.
loading
CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA.
Yao, Bing; Zhang, Qinglin; Yang, Zhou; An, Fangmei; Nie, He; Wang, Hui; Yang, Cheng; Sun, Jing; Chen, Ke; Zhou, Jingwan; Bai, Bing; Gu, Shouyong; Zhao, Wei; Zhan, Qiang.
Afiliação
  • Yao B; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China. byao@njmu.edu.cn.
  • Zhang Q; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Yang Z; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • An F; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Nie H; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Wang H; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Yang C; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Sun J; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Chen K; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Zhou J; Departments of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Department of Medical Genetics, Nanjing Medical University, Nanjing, Jiangsu Province, China.
  • Bai B; Center for Precision Medicine, Department of Laboratory Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, China.
  • Gu S; Institute of Geriatric Medicine, Jiangsu Province Geriatric Hospital, Nanjing, Jiangsu Province, China. gushouyong@jspgh.com.
  • Zhao W; Department of Biomedical Sciences and Tung Biomedical Sciences Centre, City University of Hong Kong, Hong Kong, China. wzhao42@cityu.edu.hk.
  • Zhan Q; School of laboratory medicine, Chengdu medical college, Chengdu, China. wzhao42@cityu.edu.hk.
Mol Cancer ; 21(1): 140, 2022 06 30.
Article em En | MEDLINE | ID: mdl-35773744

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas de Ligação a RNA / Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico / MicroRNAs / RNA Circular Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas de Ligação a RNA / Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico / MicroRNAs / RNA Circular Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article